Medical research is essential to develop new treatments and therapies for stroke so that patients in the UK can get the best possible care. Clinical trials are conducted to test whether a new medical intervention is safe and effective and these trials often rely on the participation of volunteer stroke survivors.
To help plan the care of stroke survivors and their rehabilitation, health professionals usually use a scale called the Barthel Index (BI) to measure how well they can perform activites of daily living (ADLs).
Visual field loss is a commonly reported side effect of stroke and can seriously impact on functional ability and quality of life. Published today in the journal, Neuro-Ophthalmology, a new study shares insights learned from recruitment of study participants to the 'VISION' trial, and how this may inform future, similar trials.
Thousands of stroke survivors with visual problems could improve their sight from the comfort of their own home using two new web-based therapies.
PRESS RELEASE - Issued by University of Leicester Press Office on Tuesday 10 May
University of Leicester involved in the international ENCHANTED trial to improve survival rates of stroke victims. Stroke Association funds UK arm of the trial.
This year, the UK Stroke Assembly North event was held in Manchester. On day two, the morning plenary was all about stroke research, including how patients can get involved in shaping it.
This research project aims to better understand how particular features of the CT scan can be used to make better treatment decisions for patients with ischaemic stroke, and whether we can accurately estimate the time since the stroke began.
Two articles published from the Nottingham Fatigue After Stroke (NOTFAST) study shed light on having fatigue six months after having a stroke.
Although stroke survivors have reported fatigue as a problem, previous estimates of the numbers of people affected have varied greatly – from one-quarter to almost three-quarters of stroke survivors.